The George Washington University (GW) School of Medicine and Health Sciences (SMHS), the GW University Hospital, and the GW Medical Faculty Associates announced the appointment of Eduardo M. Sotomayor, MD, as the inaugural Director of the GW Cancer Center (GWCC). He will also serve as a Professor of Medicine. These roles will become effective July 2015.
Dr. Sotomayor will serve as Chief Academic and Clinical Leader with responsibility and authority over all aspects of the GWCC. One of Dr. Sotomayor’s top goals will be to develop a roadmap to efficiently deliver personalized medicine at the point of care, and, in the near future, position the GWCC to join the Oncology Research Information Exchange Network, a unique research partnership of North American cancer centers who collaborate and share information to offer patients novel targeted treatments.
“I am proud to welcome Dr. Sotomayor as a member of the Department of Medicine who will advance the clinical, educational, and research mission of the department,” said Alan Wasserman, MD, Chair of the Department of Medicine and President of the GW Medical Faculty Associates.
Prior to joining the GWCC, he served as the Scientific Director of the DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center. He was also Susan and John Sykes Endowed Chair of Hematologic Malignancies and Chair of the Department of Malignant Hematology at the Moffitt Cancer Center and Research Institute. In addition, he was Professor in the Department of Oncologic Sciences and the Department of Pathology and Cell Biology at the University of South Florida College of Medicine.
“I am humbled and thrilled with my selection as the inaugural director of the GW Cancer Center,” said Dr. Sotomayor.
Dr. Sotomayor is widely recognized in the field of lymphoma research and treatment. His primary area of research is immunobiology and immunotherapy of B-cell malignancies. ■